See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Baseball
Natural Disasters
Social Media
Donald Trump
Stock Markets
Trade War
Trade
South America
Tennis
Rugby
European Union
Published • loading... • Updated

Scientists identify Alzheimer's disease-protective genetic factors and unravel disease mechanisms

Summary by Science Daily
An international research team has identified key genetic factors that confer protective effects against Alzheimer's disease (AD) through a comprehensive genetic analysis of East Asian populations, including Chinese and Japanese, as well as European populations. This groundbreaking discovery sheds light on how these genetic factors can exert protective effects, unveiling the biological mechanisms underlying AD pathogenesis.

4 Articles

All
Left
Center
1
Right
Science DailyScience Daily
Center

Scientists identify Alzheimer's disease-protective genetic factors and unravel disease mechanisms

An international research team has identified key genetic factors that confer protective effects against Alzheimer's disease (AD) through a comprehensive genetic analysis of East Asian populations, including Chinese and Japanese, as well as European populations. This groundbreaking discovery sheds light on how these genetic factors can exert protective effects, unveiling the biological mechanisms underlying AD pathogenesis.

·United States
Read Full Article
csimarket.comcsimarket.com

#Coya Therapeutics Demonstrates Promising Results in Alzheimer?s Disease with IL-2 Therapy Based on Inflammatory Blo...

Houston-based Coya Therapeutics, Inc., a clinical-stage biotechnology company focusing on the enhancement of regulatory T cell (Treg) function, has announced promising results from a recent study evaluating low-dose interleukin-2 (LD IL-2) as a potential therapeutic approach for Alzheimer's disease (AD). The company's announcement follows the completion of an investigator-initiated, 21-week, double-blind, placebo-controlled Phase 2 study that ex…

Read Full Article
Clinical Lab ProductsClinical Lab Products

Alzheimer's Disease Blood Biomarker Test Improves Clinical Decision-Making

Summary:The use of the PrecivityAD2 blood biomarker test significantly improved clinicians’ confidence in diagnosing Alzheimer’s disease, enhancing patient management and care outcomes. Takeaways: Enhanced Diagnostic Confidence: Clinicians’ certainty in diagnosing Alzheimer’s disease rose to over 90% with positive test results. Impact on Medication and Testing: Positive results led to a 35% increase in AD medication prescriptions, while negativ…

Read Full Article
Medical XpressMedical Xpress

Comprehensive genetic analysis identifies protective factors against Alzheimer's disease

An international research team led by the Hong Kong University of Science and Technology (HKUST) has identified key genetic factors that confer protective effects against Alzheimer's disease (AD) through a comprehensive genetic analysis of East Asian populations, including Chinese and Japanese, as well as European populations.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical Xpress broke the news in on Tuesday, February 4, 2025.
Sources are mostly out of (0)

Similar News Topics

Alzheimer's Disease

Alzheimer's Disease

Science

Science

Medical

Medical

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal